WallStreetZenWallStreetZen

How to Buy Humana Stock

Humana Inc

Humana is a healthcare plan company located in Kentucky, United States, which is part of the Healthcare sector, and is traded under the ticker HUM on the NYSE exchange.

Humana stock last closed at $502.43, up 2.26% from the previous day, and has increased 14.86% in one year. It has overperformed other stocks in the Healthcare Plans industry by 0.2 percentage points. Humana stock is currently +22.28% from its 52-week low of $410.87, and -12.05% from its 52-week high of $571.30.

There are currently 124.97M HUM shares outstanding. The market capitalization of HUM is $62.79B. In the last 24 hours, 659,720 HUM shares were traded.

How to Buy Humana Stock

Wondering how to invest in Humana stock? Here's how.
  1. Figure out where to buy Humana stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Humana stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Pick your payment method and add your info.
  4. Evaluate Humana stock: The Humana ticker symbol is HUM. Is Humana stock a good investment? Should you buy shares of HUM? How do HUM's underlying business fundamentals look? Do top analysts think Humana is a good buy? Why has HUM's stock price moved recently? (Hint: Our stock market research tools can help you understand if HUM is a good stock to buy).
  5. Make your HUM trade: Decide if you will purchase HUM shares at the current market price or use a limit order to purchase HUM stock at a specific price.
  6. Keep tabs on your HUM position: Create a watchlist to the latest updates on your position in Humana shares.

Step 1: Figure out where to buy Humana stock

You will need a brokerage account in order to access the NYSE market and buy HUM shares.

A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global financial markets: From Technology to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro today.

Open eToro Account

Step 2: Create a brokerage account

Now that you've selected your brokerage, you need to fill out some personal details so you are able to invest in HUM today.

How to Set Up a New Account on eToro

  1. Click here to get started.
  2. Input your personal info to open a new trading account.
  1. Submit your data by pressing the "Create Account" button.
Get started with eToro today

Step 3: Fund your brokerage account

Now that you have opened your account on a good online stock trading app, your next step is to transfer the money for your investment:

Watch the tutorial below to see the process of transferring funds into your investment account.

Get started with eToro today

Step 4: Evaluate Humana stock

Once you have identified the best place to buy Humana stock, it's absolutely critical to research their stock before you invest, so you actually understand the risk and opportunity.

Humana quick stats

HUM Price
$502.43
1w %
1.39%
1y %
14.86%
5y %
87.4%
P/E
22.63x
P/B
4.1x
P/S
0.68x
PEG
5.59x
Revenue
$92.87B
Earnings
$2.81B
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$62.79B
Next Earnings
Apr 26, 2023
Next Dividend
Apr 28, 2023

HUM Due Diligence Checks

WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis.

You can view all of the due diligence checks on HUM's stock page.

How is HUM stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge HUM's fair value.

Using relative valuations ratios:

  • HUM may be overvalued based on its P/E ratio of 22.63x, relative to Healthcare Plans industry P/E ratio of 21.09x
  • HUM may be overvalued based on its P/B ratio of 4.1x, relative to Healthcare Plans industry P/B ratio of 3.05x
  • HUM could be overvalued based on its PEG ratio of 5.59x

You can do more valuation research on HUM's stock here.

A look at HUM Cashflows and Balance Sheet

Passed Financial Due Diligence Checks:

  • HUM earnings of $3.97B is not sufficient to cover its interest payments.
  • There are more short-term assets than long-term liabilities on the HUM balance sheet.
  • There are more short-term assets than short-term liabilities on the HUM balance sheet.
  • HUM's operating cash flow of $4.59B allows it to safely service it's debt of $11.42B.

Failed Financial Due Diligence Checks:

  • Total HUM debt is higher than 5 years ago, relative to shareholder equity.
  • HUM profit margin has gone down from 3.5% to 3% in the past year.
  • HUM has a relatively high debt to equity ratio of 1.81.

Is it a good time to buy Humana stock, according to analysts?

Out of 13 Wall Street analysts who give forecasts on HUM, the consensus analyst rating on HUM is a Strong Buy

It's important to note that analyst forecasts are not recommendations, nor are they investment advice.

Most Recent HUM Analyst Recommendations

George Hill, a top 12% analyst from Deutsche Bank maintains HUM with a strong buy rating and lowers their HUM price target from $575.00 to $562.00, on Feb 28, 2023.

David S Macdonald, a top 15% analyst from Truist Securities maintains HUM with a hold rating and lowers their HUM price target from $580.00 to $560.00, on Feb 7, 2023.

Gary Taylor, a bottom 20% analyst from Cowen & Co. maintains HUM with a buy rating and lowers their HUM price target from $647.00 to $581.00, on Feb 6, 2023.

A.J. Rice, a top 6% analyst from Credit Suisse maintains HUM with a buy rating and lowers their HUM price target from $635.00 to $575.00, on Feb 6, 2023.

Scott Fidel, a top 10% analyst from Stephens & Co. maintains HUM with a strong buy rating and lowers their HUM price target from $625.00 to $590.00, on Feb 3, 2023.

You can dive deeper into what analysts are projecting on the Humana stock forecast page.

HUM Technicals

SMA10
492.56
SMA20
493.48
SMA50
495.38
SMA100
511.03
SMA200
497.96
MACD
-0.28
MACD Signal
-1.57
MACD Histogram
1.3
RSI
55.66
Stochastic %K
67.82
Stochastic %D
68.25
StochRSI %K
81.06
StochRSI %D
85.21

HUM Revenue

Last year, HUM earnings were $2.81B. Over the past five year, HUM's earnings have gone up by 5.56% per year. This was slower than the Healthcare Plans industry average of 9.73%.

Last year, HUM revenue was $92.87B. Over the last 5 year, HUM's revenue has gone up by 11.55% per year. This was slower than the Healthcare Plans industry average of 13.68%.

Learn more about HUM's earnings and revenue performance here.

Are HUM executives and large shareholders buying or selling the stock?

In the past 12 months, insiders at HUM have sold more shares than they have bought.

Bruce D. Broussard, President CEO of HUM, was the latest HUM insider to sell. They sold $8,890,225.88 worth of HUM stock on Feb 27, 2023.

Learn more about who owns HUM shares here.

Does HUM stock generate passive income?

Humana pays a dividend of 0.63%, compared to the Healthcare Plans industry's average dividend yield of 1.6%. If you owned $1,000 of HUM stock, you would have been paid $6.27 in the past 12 months.

Humana dividend payments have consistently grown over the past decade and have remained stable.

Find more info about Humana dividend yield and history here.

What others are saying about HUM

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Make your HUM trade

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are generally fine for most investors.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a specific dollar amount limit, use a limit order.

Hit the Open button and eToro will execute your order.

If you require more help buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep tabs on your HUM position

Now that you own some HUM shares, you'll want to stay up-to-date on your new investment.

Put HUM on a watchlist to keep track of your HUM stock.

HUM Feed

How to Buy Stock in Humana

To summarize, here are the 6 steps you need to take to buy Humana stock right now:

  1. Figure out where to buy Humana stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Evaluate Humana stock
  5. Make your HUM trade
  6. Keep tabs on your HUM position

If you need a brokerage account, eToro is our recommended venue.

Get Started with eToro Today

If you want to get updates on your new investment in Humana, create a watchlist on WallStreetZen today.

NYSE: HUM
$502.43+11.08 (+2.26%)
Updated Mar 24, 2023
Open eToro Account
NYSE: HUM
$502.43+11.08 (+2.26%)
Updated Mar 24, 2023
Open eToro Account

FAQ

How much does it cost to buy one Humana share?

As of Mar 24, 2023, it costs $502.43 to buy one share of Humana stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.199 shares of HUM.

Get Started with eToro Today

Is now a good time to buy Humana stock?

According to 13 Wall Street analysts who monitor Humana, their consensus recommendation is to buy Humana stock.

What is the best way to buy Humana stock?

One way to place an order for Humana stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.